PATHOBIOLOGY OF FOAM CELLS IN ATHEROSCLEROSIS
动脉粥样硬化中泡沫细胞的病理学
基本信息
- 批准号:3074211
- 负责人:
- 金额:$ 5.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1987
- 资助国家:美国
- 起止时间:1987-04-01 至 1992-03-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The emigration of monocytes from the circulation to a subendothelial
position, and their subsequent transformation into cholesteryl ester rich
foam cells is one of the earliest recognizable processes in lesion
formation. In proposed experiments, aspects of macrophage function thought
to play a role in vascular biology will be assessed. In particular, we
will investigate macrophage-derived foam cells' release and/or activation
of extracellular proteases. Secretion of soluble plasminogen activator and
expression of membrane associated activator will be determined. The
activity of other neutral proteases will also be assessed including that of
collagenase. In addition to the important role of macrophage in connective
tissue degradation and fibrinolysis, macrophage also activate proteases
involved in coagulation. Therefore, the elaboration of procoagulant
activity by macrophage-derived foam cells will be determined. Utilizing
these parameters, the relationship the cell's state of activation and its
subsequent response to lipid and/or lipoprotein accumulation will be
investigated. Finally, the effect of soluble foam cell factors on a
variety of endothelial and smooth muscle cell properties important to
vascular homeostasis will be investigated. These include plasminogen
activator/inhibitor activities, release of collagenase, degradation of
cell-derived matrix, expression of procoagulant activity and reactivity to
monocytes. Elucidation of how macrophage-derived foam cells may directly
or indirectly contribute to or modulate these processes by other cells will
contribute significantly to our understanding of lesion progression.
单核细胞从循环中迁移到内皮下
位置,以及随后转化为富含胆固醇酯
泡沫细胞是最早发现的病变过程之一
阵 在拟议的实验中,巨噬细胞功能方面的思想
在血管生物学中发挥作用。 我们尤其
将研究巨噬细胞源性泡沫细胞的释放和/或激活
细胞外蛋白酶。 可溶性纤溶酶原激活物的分泌,
将测定膜相关激活剂的表达。 的
还将评估其它中性蛋白酶的活性,包括
胶原酶 除了巨噬细胞在结缔组织中的重要作用外,
组织降解和纤维蛋白溶解,巨噬细胞还激活蛋白酶
参与凝血。 因此,对促凝血剂的阐述
测定巨噬细胞衍生的泡沫细胞的活性。 利用
这些参数,细胞的激活状态与其
随后对脂质和/或脂蛋白积累反应将
研究了 最后,研究了可溶性泡沫细胞因子对
内皮细胞和平滑肌细胞的各种特性对
将研究血管稳态。 这些包括纤溶酶原
激活剂/抑制剂活性,胶原酶的释放,
细胞衍生基质,促凝血活性的表达和对
单核细胞 阐明巨噬细胞源性泡沫细胞如何直接
或间接促进或调节这些过程的其他细胞将
有助于我们理解病变进展。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOMENICK J FALCONE其他文献
DOMENICK J FALCONE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOMENICK J FALCONE', 18)}}的其他基金
PGE2 receptors: therapeutic targets in occlusive and aneurysmal vascular diseases
PGE2 受体:闭塞性和动脉瘤性血管疾病的治疗靶点
- 批准号:
8208059 - 财政年份:2010
- 资助金额:
$ 5.39万 - 项目类别:
PGE2 receptors as therapeutic targets in occlusive and aneurysmal vascular diseas
PGE2 受体作为闭塞性和动脉瘤性血管疾病的治疗靶点
- 批准号:
8010647 - 财政年份:2010
- 资助金额:
$ 5.39万 - 项目类别:
PGE2 receptors: therapeutic targets in occlusive and aneurysmal vascular diseases
PGE2 受体:闭塞性和动脉瘤性血管疾病的治疗靶点
- 批准号:
8410584 - 财政年份:2010
- 资助金额:
$ 5.39万 - 项目类别:
PGE2 receptors as therapeutic targets in occlusive and aneurysmal vascular diseas
PGE2 受体作为闭塞性和动脉瘤性血管疾病的治疗靶点
- 批准号:
7782971 - 财政年份:2010
- 资助金额:
$ 5.39万 - 项目类别:
REGULATION OF MACROPHAGE PLASMINOGEN ACTIVATION AND VASCULAR REMODELING
巨噬细胞纤溶酶原激活和血管重塑的调节
- 批准号:
6442297 - 财政年份:2001
- 资助金额:
$ 5.39万 - 项目类别:
REGULATION OF MACROPHAGE PLASMINOGEN ACTIVATION AND VASCULAR REMODELING
巨噬细胞纤溶酶原激活和血管重塑的调节
- 批准号:
6302472 - 财政年份:2000
- 资助金额:
$ 5.39万 - 项目类别:
相似海外基金
Novel mechanisms linking blood coagulation to liver fibrosis
将凝血与肝纤维化联系起来的新机制
- 批准号:
10722686 - 财政年份:2023
- 资助金额:
$ 5.39万 - 项目类别:
Lipid peroxidation- and pyroptosis-induced tissue factor activation in pathogen-induced blood coagulation
病原体诱导的血液凝固中脂质过氧化和焦亡诱导的组织因子激活
- 批准号:
10571353 - 财政年份:2023
- 资助金额:
$ 5.39万 - 项目类别:
Elucidation of changes in electrical properties during the blood coagulation process and its use for measurement of blood coagulation status during extracorporeal circulation
阐明血液凝固过程中电特性的变化及其在体外循环期间血液凝固状态测量中的应用
- 批准号:
23K08266 - 财政年份:2023
- 资助金额:
$ 5.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
SBIR Phase II: Innovative Platform for Low Volume Blood Coagulation Analysis
SBIR II 期:低容量凝血分析的创新平台
- 批准号:
2134020 - 财政年份:2022
- 资助金额:
$ 5.39万 - 项目类别:
Cooperative Agreement
Construction of a multilayered network to represent blood coagulation process
构建代表血液凝固过程的多层网络
- 批准号:
22K12252 - 财政年份:2022
- 资助金额:
$ 5.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Protein S Regulates Blood Coagulation by Inhibiting Factor IXa
Protein S 通过抑制 IXa 因子调节凝血
- 批准号:
10616732 - 财政年份:2022
- 资助金额:
$ 5.39万 - 项目类别:
Development of thrombus prevention technology for ECMO devices based on the blood coagulation mechanism caused by viral infections
基于病毒感染凝血机制的ECMO装置血栓预防技术开发
- 批准号:
21K08817 - 财政年份:2021
- 资助金额:
$ 5.39万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Novel mechanisms linking blood coagulation to liver fibrosis
将凝血与肝纤维化联系起来的新机制
- 批准号:
10452687 - 财政年份:2021
- 资助金额:
$ 5.39万 - 项目类别:
SBIR Phase II: CoagCare-A POC Blood Coagulation Diagnostic Platform That Utilizes A Hand-held Meter and Mechanically Sensitive Test Strips for Broad Spectrum Hemostasis Monitoring
SBIR II 期:CoagCare - POC 凝血诊断平台,利用手持式仪表和机械敏感试纸条进行广谱止血监测
- 批准号:
2050272 - 财政年份:2021
- 资助金额:
$ 5.39万 - 项目类别:
Cooperative Agreement
Novel mechanisms linking blood coagulation to liver fibrosis
将凝血与肝纤维化联系起来的新机制
- 批准号:
10283268 - 财政年份:2021
- 资助金额:
$ 5.39万 - 项目类别: